Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA.
Center for Infection and Immunity, Columbia Mailman School of Public Health, New York, NY 10032, USA; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Cell Rep. 2020 Feb 11;30(6):1702-1713.e6. doi: 10.1016/j.celrep.2020.01.026.
Host response to infection is a major determinant of disease severity in Ebola virus disease (EVD), but gene expression programs associated with outcome are poorly characterized. Collaborative Cross (CC) mice develop strain-dependent EVD phenotypes of differential severity, ranging from tolerance to lethality. We screen 10 CC lines and identify clinical, virologic, and transcriptomic features that distinguish tolerant from lethal outcomes. Tolerance is associated with tightly regulated induction of immune and inflammatory responses shortly following infection, as well as reduced inflammatory macrophages and increased antigen-presenting cells, B-1 cells, and γδ T cells. Lethal disease is characterized by suppressed early gene expression and reduced lymphocytes, followed by uncontrolled inflammatory signaling, leading to death. We apply machine learning to predict outcomes with 99% accuracy in mice using transcriptomic profiles. This signature predicts outcomes in a cohort of EVD patients from western Africa with 75% accuracy, demonstrating potential clinical utility.
宿主对感染的反应是埃博拉病毒病(EVD)严重程度的主要决定因素,但与结局相关的基因表达程序特征描述不足。合作性交叉(CC)小鼠表现出依赖于菌株的 EVD 表型,严重程度不同,从耐受到致死不等。我们筛选了 10 个 CC 系,并确定了可区分耐受和致死结果的临床、病毒学和转录组特征。耐受与感染后不久免疫和炎症反应的严格调节有关,以及炎症性巨噬细胞减少和抗原呈递细胞、B-1 细胞和 γδ T 细胞增加有关。致命疾病的特征是早期基因表达和淋巴细胞减少受到抑制,随后炎症信号失控,导致死亡。我们应用机器学习使用转录组谱以 99%的准确率预测小鼠的结果。该特征可在来自西非的 EVD 患者队列中以 75%的准确率预测结果,显示出潜在的临床应用价值。